首页 > 产品中心 > 抗体 > 药物对照抗体

Research Grade Onartuzumab (HY196026)

价格:
规格:
  • 100ug
  • 1mg
数量:
  • 概述
  • 图片
  • 参考文献
  • 产品说明书
概述
货号HY196026
品牌abinScience
种属反应性Human
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主Humanized
同种型Fab-G1-kappa-[Fc-G1]
表达系统Mammalian Cells
克隆类型Monoclonal
靶标Tyrosine-protein kinase Met, Hepatocyte growth factor receptor, Proto-oncogene c-Met, Scatter factor receptor, HGF receptor, SF receptor, HGF/SF receptor, MET
内毒素水平Please contact the lab for this information.
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
Accession号P08581
状态Liquid
保存溶液0.01M PBS, pH 7.4.
稳定性和存储Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
别名tMAb, OA-5DMe5, PRO143966, 1133766-06-9
背景Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic.
• MET-dependent solid tumours - molecular diagnosis and targeted therapy., PMID:32514147
• ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence., PMID:27573171
• Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis., PMID:34848680
• The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance., PMID:30786811
• The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions., PMID:26822708
• MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomas., PMID:34667077
• Targeting HGF/c-MET Axis in Pancreatic Cancer., PMID:33271944
• Targeting the hepatocyte growth factor/Met pathway in cancer., PMID:28673936
• Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases., PMID:30658428
• Hepatocyte growth factor in physiology and infectious diseases., PMID:28094206
NoteFor research use only. Not suitable for clinical or therapeutic use.
图片
  • Bioactivity

    SEC-HPLC detection for Research Grade Onartuzumab.

相关产品推荐